Tofacitinib Treatment for Pretibial Myxedema-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tofacitinib Treatment for Pretibial Myxedema

Published:2024-05-01 Issue:5 Volume:160 Page:578
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Wang Su¹,Chen Xinyi¹,Bai Juan¹,Sun Qingmiao¹,Fang Hong¹,Qiao Jianjun¹

Affiliation:

1. Department of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Abstract

This case report describes tofacitinib treatment for 2 patients with pretibial myxedema.

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jamadermatology/articlepdf/2817137/jamadermatology_wang_2024_lo_240002_1715718020.64998.pdf

Reference6 articles.

1. Pretibial myxedema: pathophysiology and treatment options.;Fatourechi;Am J Clin Dermatol,2005

2. Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer.;Xue;Signal Transduct Target Ther,2023

3. Local immune microenvironment of skin may play an important role in the development of pretibial myxedema.;Chen;Exp Dermatol,2021

4. Teprotumumab as a novel treatment for pretibial myxoedema.;Mervis;Br J Dermatol,2022

5. A case of pretibial myxedema treated with teprotumumab.;Petit;JAAD Case Rep,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP